What is Agios Pharmaceuticals's net change in cash?

Agios Pharmaceuticals (AGIO) reported net change in cash of $24.47M in Q1 2026.

How has Agios Pharmaceuticals's net change in cash changed year-over-year?

Agios Pharmaceuticals's net change in cash increased by 800.6% year-over-year, from $2.72M to $24.47M.

What does net change in cash mean?

Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.

Agios Pharmaceuticals AGIO Net Change in Cash

Net Change in Cash at other companies

Bristol-Myers SquibbBMY

-$635M-220%

PfizerPFE

$563M+50.1%

Vertex PharmaceuticalsVRTX

$417.1M+268%

IncyteINCY

$363.28M+43.1%

BioMarin PharmaceuticalsBMRN

$1.76B+1,562%

Disc MedicineIRON

-$2.23M+96.8%

Other financials

Income statement

See full

Revenue$20.7M+138%

Gross profit$19.4M+154%

Operating income-$110.0M-3.2%

Net income-$99.1M-11.0%

EPS (diluted)-$1.69-9.0%

Balance sheet

See full

Cash & equivalents$113.6M+43.9%

Total debt$35.7M-32.5%

Total equity$1.1B-24.4%

Total assets$1.2B-23.8%

Cash flow

See full

Operating cash flow-$118.9M-6.7%

CapEx$769.0K+0.4%

Free cash flow-$119.7M-6.6%

Valuation

See full

Market cap$2.12B+18.1%

Enterprise value$2.04B+15.2%

P/S32.1×-16.4×

Profitability

See full

Gross margin90%+2.5pp

Operating margin-720%-204pp

Net margin-639.8%—

FCF margin-582.5%-185pp

Returns & leverage

See full

Return on equity-32.8%—

Debt / equity0×0.0×

Current ratio14.2×-4.3×

Where this comes from

Reported directly by Agios Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The official record: Agios Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Agios Pharmaceuticals's net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Agios Pharmaceuticals's net change in cash?: Agios Pharmaceuticals (AGIO) reported net change in cash of $24.47M in Q1 2026.
How has Agios Pharmaceuticals's net change in cash changed year-over-year?: Agios Pharmaceuticals's net change in cash increased by 800.6% year-over-year, from $2.72M to $24.47M.
What does net change in cash mean?: Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.